Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT04097353
What this trial is testing

Improving Health Behaviors for Pediatric Cancer Survivors

Who this might be right for
Cancer
Cynthia Gerhardt 31
Not applicableStudy completedNCT06061302
What this trial is testing

Multiple Myeloma Yoga Pilot Study

Who this might be right for
Multiple Myeloma
University of Arizona 31
Early research (Phase 1)Ended earlyNCT06540066
What this trial is testing

BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerAdvanced Solid TumorMetastatic Cancer+1 more
BeiGene 35
Early research (Phase 1)Looking for participantsNCT06686745
What this trial is testing

Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Large-scale testing (Phase 3)Study completedNCT03223753
What this trial is testing

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

Who this might be right for
Carcinoma In SituHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Children's Oncology Group 299
Early research (Phase 1)Study completedNCT03733951
What this trial is testing

KN046 in Subjects With Advanced Solid Tumors and Lymphoma

Who this might be right for
Advanced Solid TumorsLymphoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 139
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Not applicableLooking for participantsNCT06550687
What this trial is testing

Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.

Who this might be right for
All Types of Metastatic Solid Malignancy1st-line TreatmentExome Analysis+1 more
Centre Georges Francois Leclerc 80
Early research (Phase 1)Ended earlyNCT06466187
What this trial is testing

SGN-MesoC2 in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more
Seagen, a wholly owned subsidiary of Pfizer 19
Large-scale testing (Phase 3)Study completedNCT04102098
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 668
Not applicableStudy completedNCT03975621
What this trial is testing

Nurse AMIE: Addressing Metastatic Individuals Everyday

Who this might be right for
Metastatic Breast Cancer
Milton S. Hershey Medical Center 21
Very early researchLooking for participantsNCT06822998
What this trial is testing

HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
HighField Biopharmaceuticals Corporation 10
Testing effectiveness (Phase 2)Ended earlyNCT03386721
What this trial is testing

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers
Hoffmann-La Roche 256
Testing effectiveness (Phase 2)Ended earlyNCT00101621
What this trial is testing

Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain

Who this might be right for
CancerPain
MetaPhore Pharmaceuticals 24
Not applicableUnknownNCT06275321
What this trial is testing

Physical Exercise Benefits for Cancer Patients

Who this might be right for
Cancer, BreastSports Physical Therapy
Universitat Jaume I 60
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Early research (Phase 1)Ended earlyNCT06194877
What this trial is testing

Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Who this might be right for
Colorectal CancerPancreatic Ductal CancerAdvanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers
MapKure, LLC 13
Early research (Phase 1)Not Yet RecruitingNCT06866795
What this trial is testing

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Geode Therapeutics Inc. 42
Not applicableUnknownNCT04116827
What this trial is testing

Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device

Who this might be right for
Sleep DisorderBreast Cancer
Samsung Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT04811027
What this trial is testing

Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC

Who this might be right for
HNSCC
Immutep S.A.S. 171
Next Page